06.01.24 Head MDL judge appointed Judge Karen Marston was appointed to head the MDL after Judge Pratters death in May
Tirzepatide functions as both a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist
Retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and no marketing authorisation application has been approved as of the date of publication of this article
It is worth noting that for currently licensed GLP-1 receptor agonists in the UK, the thyroid tumour signal is classified as a precautionary consideration based on rodent data, rather than a formal contraindication as reflected in UK Summaries of Product Characteristics (SmPCs)
Its high-strength concentration allows for flexible and controlled usage where precision and consistency are critical
Targeting the Root Causes of Weight Gain Many patients struggle with underlying metabolic, hormonal, or gut health imbalances